Perspective - Journal of Child and Adolescent Health (2024) Volume 8, Issue 4
Microbiome in modulating vaccine responses and immune maturation in early childhood
Thomas Wesley*
Department of Microbiology and Immunology, Columbia University, New York, USA
- Corresponding Author:
- Thomas Wesley
Department of Microbiology and Immunology,
Columbia University,
New York,
USA
E-mail: thomas@wesley.edu
Received: 08-Aug-2023, Manuscript No. AAJCAH-23-109677; Editor assigned: 11-Aug-2023, AAJCAH-23-109677 (PQ); Reviewed: 25-Aug-2023, QC No. AAJCAH-23-109677; Revised: 29-Jul-2024, Manuscript No. AAJCAH-23-109677 (R); Published: 05-Aug-2024, DOI:10.35841/aajcah.8.4.216
Citation: Wesley T. Microbiome in modulating vaccine responses and immune maturation in early childhood. J Child Adolesc Health. 2024;8(4):1-2.
Introduction
The human microbiome, comprising trillions of microorganisms living in and on our bodies, has emerged as a critical player in shaping various aspects of human health and disease. Recent research has shown that the microbiome plays a vital role in modulating immune responses and influencing the efficacy of vaccines, particularly during early childhood. This article aims to explore the intricate relationship between the microbiome, vaccine responses, and immune maturation in young children, shedding light on the potential implications for optimizing vaccination strategies and enhancing overall pediatric health [1].
The human microbiome consists of a diverse array of bacteria, viruses, fungi, and other microorganisms that coexist in harmony with our cells. The majority of these microorganisms reside in the gastrointestinal tract, forming what is known as the gut microbiome [2]. However, the skin, respiratory tract, and other mucosal surfaces also harbor significant microbial populations. During early childhood, the developing immune system interacts extensively with the microbiome, leading to the establishment of a stable microbial community. This process is influenced by various factors, including mode of birth (vaginal delivery or cesarean section), breastfeeding, diet, exposure to pathogens, and environmental factors [3].
Description
The microbiome is instrumental in shaping the development and maturation of the immune system in early life. Cross-talk between gut microbes and immune cells helps train the immune system to distinguish between harmless and harmful entities, leading to immune tolerance and preventing unnecessary inflammatory responses to harmless antigens. Studies have revealed that certain beneficial gut bacteria, such as Bifidobacteria and Lactobacillus species, can stimulate the production of regulatory T cells, which play a crucial role in maintaining immune balance and preventing autoimmune reactions. On the other hand, dysbiosis or an imbalance in the gut microbiome has been associated with increased susceptibility to infections and the development of immunerelated disorders [4].
Preclinical studies in animal models have demonstrated that the gut microbiome can influence the outcome of vaccination.
Certain gut bacteria can promote the production of antibodies, enhance the activation of immune cells, and improve the overall effectiveness of vaccination. Conversely, an altered or impoverished gut microbiome may lead to suboptimal vaccine responses, resulting in reduced protection against infectious diseases [5].
"Gut-immune axis" in early childhood vaccination
In early childhood, the gut microbiome interacts closely with the developing immune system, forming what is often referred to as the "gut-immune axis". This dynamic relationship can influence the immune response to vaccines during this critical period of immune maturation.
• The gut microbiome can influence the activity of innate
immune cells, such as dendritic cells and macrophages,
which are crucial for initiating and shaping the adaptive
immune response following vaccination.
• The gut microbiome can influence the development of B
cells and T cells, the two main arms of the adaptive immune
system. Certain gut bacteria have been shown to enhance
the generation of vaccine-specific memory T cells and
antibody-secreting B cells, leading to improved immune
memory and long-lasting protection.
• Proper immune tolerance is crucial for preventing excessive
inflammation and immune-related disorders. The
microbiome helps establish immune tolerance by promoting
the development of regulatory T cells and other regulatory
immune cells.
Conclusion
The human microbiome plays a vital role in modulating vaccine responses and influencing immune maturation in early childhood. Understanding the complex interactions between the gut microbiome and the developing immune system could open new avenues for optimizing vaccination strategies, enhancing vaccine efficacy, and promoting overall pediatric health. Future research in this field holds promise for advancing precision medicine approaches and improving the outcomes of childhood vaccination programs.
References
- Ghorbani M, Dolatian M, Shams J, et al. Factors associated with posttraumatic stress disorder and its coping styles in parents of preterm and full-term infants. Glob J Health Sci. 2014;6(3):65-73.
[Crossref] [Google Scholar] [PubMed]
- Lundqvist P, Hellstrom-Westas L, Hallstrom I. Reorganizing life: A qualitative study of fathers' lived experience in the 3 years subsequent to the very preterm birth of their child. J Pediatr Nurs. 2014;29(2):124-31.
[Crossref] [Google Scholar] [PubMed]
- Chawanpaiboon S, Vogel JP, Moller AB, et al. Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Glob Health. 2019;7(1):e37-46.
[Crossref] [Google Scholar] [PubMed]
- Malin KJ, Johnson TS, McAndrew S, et al. Infant illness severity and perinatal post-traumatic stress disorder after discharge from the neonatal intensive care unit. Early Hum Dev. 2020;140:104930. [Crossref]
[Google Scholar] [PubMed]
- Loewenstein K. Parent psychological distress in the neonatal intensive care unit within the context of the social ecological model: a scoping review. J Am Psychiatr Nurses Assoc. 2018;24(6):495-509.
[Crossref] [Google Scholar] [PubMed]